drug pricing

PBMs, drugmakers face off over copay accumulators
PBMs, drugmakers face off over copay accumulators
Medical Marketing and Media
PBMs
PhRMA
drug pricing
copays
Flag link:
Healthcare on the Hill - Transparent Health Care Pricing Act of 2018 (H. R. 4808)
Healthcare on the Hill - Transparent Health Care Pricing Act of 2018 (H. R. 4808)
CP Wire
transparency
drug pricing
Healthcare on the Hill
Flag link:
Transparency Is All The Rage In State Legislatures
Transparency Is All The Rage In State Legislatures
CP Wire
legistlation
transparency
drug pricing
Flag link:
Challenged by generics industry, Maryland's drug pricing law found unconstitutional
Challenged by generics industry, Maryland's drug pricing law found unconstitutional
Fierce Pharma
Maryland
drug pricing
generics
Flag link:
Novartis CEO: How To Create Cheaper Alternatives To The Most Expensive Drugs
Novartis CEO: How To Create Cheaper Alternatives To The Most Expensive Drugs
Forbes
Novartis
Pharma CEOs
FDA
drug pricing
Vasant Narasimham
Flag link:
CVS Health launches drug-pricing tool for pharmacies
CVS Health launches drug-pricing tool for pharmacies
Drug Delivery Business News
CVS Health
drug pricing
consumers
Flag link:
CVS points finger back at pharma for drug prices
CVS points finger back at pharma for drug prices
Biopharma Dive
CVS Health
PBMs
drug pricing
Flag link:
Ohio bans pharmacy gag clauses, clawbacks
Ohio bans pharmacy gag clauses, clawbacks
Biopharma Dive
pharmacy gag clauses
PBMs
payers
Ohio
drug pricing
clawbacks
Flag link:
Is Amgen’s Outcomes-Based Pricing Model for Repatha Benefiting Patients and Payers?
Is Amgen’s Outcomes-Based Pricing Model for Repatha Benefiting Patients and Payers?
Xtalks
Amgen
Repatha
outcome-based pricing
drug pricing
patients
Flag link:
Payer Power: Why Eli Lilly, Janssen, and Merck Deeply Discount Their Drug Prices
Payer Power: Why Eli Lilly, Janssen, and Merck Deeply Discount Their Drug Prices
Drug Channels
Eli Lilly
Janssen
Merck
drug pricing
drug discounts
Flag link:
Lawmakers demand details on 1,400% price hike for cancer drug
Lawmakers demand details on 1,400% price hike for cancer drug
Biopharma Dive
drug pricing
Tri-Source Pharma
NextSource Biotechnology
Gleostine
lomustine
Flag link:
Trump Tariffs Target Key Ingredients for Dozens of Drugs
Trump Tariffs Target Key Ingredients for Dozens of Drugs
Bloomberg
Donald Trump
China
tariffs
drug pricing
Flag link:
Celgene, AbbVie extracted higher prices in Q4 as other pharmas netted less: report
Celgene, AbbVie extracted higher prices in Q4 as other pharmas netted less: report
Fierce Pharma
Celgene
AbbVie
drug pricing
Flag link:
PhRMA argues early notice of price hikes won't benefit patients
PhRMA argues early notice of price hikes won't benefit patients
Biopharma Dive
PhRMA
drug pricing
consumers
PBMs
Flag link:
Medicare puts off decision on lowering drug prices patients pay at the pharmacy
Medicare puts off decision on lowering drug prices patients pay at the pharmacy
Stat
Medicare
drug pricing
PBMs
Medicare Part D
Flag link:
Teva, Valeant price-hike plans trigger warnings under California's new transparency law: report
Teva, Valeant price-hike plans trigger warnings under California's new transparency law: report
Fierce Pharma
Teva Pharmaceutical
Valeant Pharmaceuticals
drug pricing
California
transparency
Flag link:
Half-off sale at Eli Lilly as drug rebating climbs to 51% in 2017
Half-off sale at Eli Lilly as drug rebating climbs to 51% in 2017
Fierce Pharma
Eli Lilly
drug rebates
drug pricing
diabetes
Flag link:
Azar taps former CVS executive to help lower drug prices
Azar taps former CVS executive to help lower drug prices
The Hill
HHS
Alex Azar
drug pricing
Daniel Best
CVS Caremark
Flag link:
The Call For Drug-Price Transparency Is Growing Louder -- But Will It Matter?
The Call For Drug-Price Transparency Is Growing Louder -- But Will It Matter?
Forbes
drug pricing
transparency
Flag link:
Will PBMs take heat for high drug prices?
Will PBMs take heat for high drug prices?
Medical Marketing and Media
PBMs
drug pricing
Flag link:

Pages